Patent Assignment
Reel/Frame 058869/0764
Assignment of Assignor's Interest
Recorded: 2021-11-10
Pages: 64
Assignors
LI, CHI-CHUNG
Executed: 2021-06-23
O'HEAR, CAROL ELAINE
Executed: 2021-02-24
SIMKO, STEPHEN JAMES, III
Executed: 2021-06-09
TO, IRIS TRANTHUYNGAN
Executed: 2021-06-09
TOTPAL, KLARA
Executed: 2021-06-23
WANG, HONG
Executed: 2021-06-09
WEI, MICHAEL C.
Executed: 2021-06-09
YIN, SHEN
Executed: 2021-06-09
BENDER, BRENDAN CHRISTIAN
Executed: 2021-06-09
CHEN, XI
Executed: 2021-06-09
CHU, YU-WAYE
Executed: 2021-06-09
HRISTOPOULOS, MARIA
Executed: 2021-06-09
Assignee
GENENTECH, INC.
1 DNA WAY, SOUTH SAN FRANCISCO, CALIFORNIA, 94080-4990
Covered Properties
(3)
Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates
Application:
63/109,781 →
Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates
Application:
63/188,695 →
Dosing for Treatment with Anti-CD20/Anti-CD3 Bispecific Antibodies and Anti-CD79B Antibody Drug Conjugates
Patent:
12,516,118 →
Application:
17/516,979 →
Publication:
US 2022/0153842
PCT:
PCT/US2021/057714 ↗